← Back to Search

Orthopedic Implant

Total Hip Arthroplasty for Osteoarthritis (PIN DM Trial)

N/A
Waitlist Available
Research Sponsored by DePuy Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
or dislocation risks.
Individuals who are able to speak, read and comprehend the informed patient consent document and willing and able to provide informed patient consent for participation in the study and have authorized the transfer of his/her information to DePuy Synthes.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

PIN DM Trial Summary

This trial is testing a new hip implant to see how well it works compared to a similar device.

Eligible Conditions
  • Osteoarthritis
  • Joint Replacement

PIN DM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

PIN DM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Mean superior cup migration (subsidence) at 2 years
Secondary outcome measures
Cup Positioning at 12 months
Cup Positioning at 24 months
Cup Positioning at 6 weeks
+49 more
Other outcome measures
Acetabular cup subsidence with a prior to discharge baseline
Correlation of functional and health status outcomes vs. RSA
Mean change from baseline values of Harris Hip Score, HOOS Jr. and Forgotten Joint Score
+1 more

PIN DM Trial Design

2Treatment groups
Experimental Treatment
Group I: Total Hip ArthroplastyExperimental Treatment1 Intervention
Pinnacle acetabular shells used with PINNACLE DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses
Group II: Revision Total Hip ArthroplastyExperimental Treatment1 Intervention
Pinnacle acetabular shells used with Pinnacle DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Total Hip Arthroplasty
2022
Completed Phase 4
~920

Find a Location

Who is running the clinical trial?

DePuy OrthopaedicsLead Sponsor
78 Previous Clinical Trials
25,660 Total Patients Enrolled
44 Trials studying Osteoarthritis
10,902 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for enrollment in this research endeavor at the present time?

"According to information on clinicaltrials.gov, this medical research is actively seeking participants. The trial was initially posted on October 6th 2022 and recently updated November 28th 2022."

Answered by AI

How many individuals are being recruited to participate in this trial?

"This study necessitates the involvement of 45 eligible patients. DePuy Orthopaedics have appointed various sites to conduct the trial, which include Concordia Joint Replacement Group & Concordia Hip and Knee Institute in Winnipeg as well as QEII Health Sciences Centre & Dalhousie University in Halifax."

Answered by AI
~5 spots leftby Mar 2025